Acupuncture Tied to Improvements in Poststroke Motor Aphasia

26 Jan 2024
Clinical Result
FRIDAY, Jan. 26, 2024 -- Acupuncture may improve language function in patients with poststroke motor aphasia, according to a study published online Jan. 22 in JAMA Network Open.
Boxuan Li, from the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine in China, and colleagues investigated the effects of acupuncture on language function, neurological function, and quality of life in patients with poststroke motor aphasia. The analysis included 252 adult patients with poststroke motor aphasia (Oct. 21, 2019, to Nov. 13, 2021) randomly assigned to six weeks of manual acupuncture or sham acupuncture.
The researchers found that compared with sham treatment, the manual acupuncture group had significant increases in aphasia quotient (AQ) of the Western Aphasia Battery (difference, 7.99 points) and Chinese Functional Communication Profile (CFCP) scores (difference, 23.51 points) at week 6. These significant improvements persisted at six-month follow-up (AQ: difference, 10.34; CFCP: difference, 27.43).
"The study results confirmed that poststroke motor aphasia was the dominant condition affected by the acupuncture treatment, indicating that acupuncture might serve as an adjunctive treatment for patients with poststroke motor aphasia," the authors write. "In addition, the clinical effects and safety results provide evidence for policymakers, clinicians, and patients regarding the management of poststroke aphasia with acupuncture."
Abstract/Full Text
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Posted January 2024
More news resources
FDA Medwatch Drug Alerts
Daily MedNews
News for Health Professionals
New Drug Approvals
New Drug Applications
Drug Shortages
Clinical Trial Results
Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Targets
-
Drugs
-
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.